Shares of Skye Bioscience, Inc. (NASDAQ:SKYE – Get Free Report) traded up 2.8% during mid-day trading on Monday . Get Skye Bioscience alerts:View Our Latest Report on SKYESkye Bioscience Stock Down 2.3%The company has a market cap of $19.74 million, a P/E ratio of -0.39 and a beta of 2.97. Skye Bioscience (NASDAQ:SKYE – Get Free Report) last posted its quarterly earnings results on Monday, May 11th. As a group, sell-side analysts expect that Skye Bioscience, Inc. will post -1.06 EPS for the current fiscal year. See AlsoReceive News & Ratings for Skye Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skye Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.